Latest Strategic Initiatives News

EDU Holdings has completed a selective buyback of 18 million shares, reducing its issued capital by 12.5% and aiming to boost earnings per share immediately.

Austral Resources has executed binding agreements to acquire the Lady Loretta mine from Glencore and plans to repay its Rocklands Facility debt, positioning itself as a debt-free copper producer with enhanced financial flexibility.

GWA Group Limited reported solid half-year growth in revenue and earnings, driven by volume gains and strategic initiatives including a new AI partnership. The company also lifted its interim dividend, signalling confidence despite mixed market conditions ahead.

Fiducian Group’s FY2026 half-year results reveal robust growth with a 9% rise in funds under management and a 17% jump in underlying net profit, despite ongoing regulatory challenges.

iCandy Interactive’s subsidiary Lemon Sky Studios has appointed a seasoned industry leader to drive global partnerships, secured over A$1 million in recent contracts, and is exploring strategic options to unlock shareholder value.

Coast Entertainment Holdings Limited has reported a robust first half of FY26, with record-breaking visitor numbers and a sharp rise in earnings driven by new attractions and strategic partnerships.

Coast Entertainment Holdings Limited reported a robust 30.2% increase in revenue to $62.165 million for the half year ended December 2025, alongside a modest 1.4% rise in net profit. The company also completed a significant 10% on-market share buy-back.

Vysarn Limited and the Kariyarra Aboriginal Corporation have advanced their Kariyarra Water Scheme with a key groundwater licence application and a bid to supply bulk water to Port Hedland.

Westpac Banking Corporation reported a 6% rise in net profit for the first quarter of 2026, underpinned by strong capital ratios and ongoing transformation initiatives. The bank’s strategic focus on customer service and operational efficiency signals a confident outlook amid evolving market conditions.

Invex Therapeutics reports a net loss of $715,582 for H1 2026 while advancing its Exenatide program targeting neurological diseases, alongside notable board reshuffles.

AMP reported a 20.8% rise in underlying net profit after tax for FY25, powered by strong cashflows from its North platform and the successful launch of AMP Bank GO. The company also declared a final dividend and announced a CEO transition.

AMP Limited reported a 20.8% rise in underlying net profit after tax for 2025, driven by growth in wealth platforms and investments, alongside a planned CEO transition and pending class action settlements.